Patient knowledge of atrial fibrillation: 3‐month follow‐up after an emergency room visit

Koponen, Leena; Rekola, Leena; Ruotsalainen, Taru; Lehto, Mika; Leino‐Kilpi, Helena; Voipio‐Pulkki, Liisa‐Maria

doi:10.1111/j.1365-2648.2007.04465.x

Cited by 37 publications

(51 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…13 When we compared the response from Hong Kong patients in questions from the UK survey (questions 1, 3, 6, and 7; maximum score of 4) and the Finland survey (questions 4, 9, 11, 12; maximum score of 8), the mean score of Hong Kong patient was 1.16 out of 4 and 2.77 out of 8, respectively. 12,13 The mean score in Hong Kong patients was much lower than UK patients (mean score 2.24 out of 4, P < 0.001) 12 and patients in Finland (mean score, 5.94 out of 8; P < 0.001). 13 Patients Knowledge of Warfarin Therapy: A total of 114 patients were recruited in this part of questionnaire, including the 70 patients who participated in the previous AF knowledge questionnaire and 44 patients without AF but who were using warfarin for stroke prevention.…”

Section: Questionnaire For Patientsmentioning

confidence: 82%

“…A deficiency in understanding of their own disease and warfarin may mean that the patients do not know the necessity of treatment, which may lead to noncompliance of warfarin therapy, and in turn influence both physicians' and patients' preference on antithrombotic agent for stroke prevention therapy. 12 Patients' lack of knowledge of warfarin and AF may be due to limited consultation time during medical appointments in Hong Kong. Warfarin therapy is challenging for both physicians and patients due to frequent blood monitoring, narrow therapeutic index, and drug-drug and drug-food interactions.…”

Section: Discussionmentioning

confidence: 99%

“…In the United Kingdom, 49% of patients with AF were aware that their heart condition was known as atrial fibrillation, whereas none of the Hong Kong patients with AF knew the exact name of their cardiac condition. 12 Fewer patients in this study knew the increased risk of stroke in AF than 168 Clin. Cardiol.…”

Section: Questionnaire For Patientsmentioning

confidence: 90%

“…36, 3, 166-171 (2013) in the United Kingdom (HK 33% vs UK 54%). 12 Compared to patients in Finland, more Hong Kong patients (70%) did exercise normally during AF than for patients in Finland (35%), 13 but fewer Hong Kong patients (<25%) knew the symptoms of AF than did patients in Finland (>80%). 13 When we compared the response from Hong Kong patients in questions from the UK survey (questions 1, 3, 6, and 7; maximum score of 4) and the Finland survey (questions 4, 9, 11, 12; maximum score of 8), the mean score of Hong Kong patient was 1.16 out of 4 and 2.77 out of 8, respectively.…”

Section: Questionnaire For Patientsmentioning

confidence: 94%

“…We adopted the original questionnaire by Gattellari et al in English for the physicians. 11 The questionnaire for patients was designed based on 2 previously published surveys conducted in the United Kingdom 12 and Finland, 13 and translated into the traditional Chinese version and validated.…”

Section: Methodsmentioning

confidence: 99%

See 4 more Smart Citations

Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong

Lee

Tam

Yan

et al. 2012

Clinical Cardiology

View full text Add to dashboard Cite

Background:Oral anticoagulation medications such as warfarin reduce the risk of stroke in atrial fibrillation (AF) but have been underutilized. This study aimed to investigate physicians' perceptions of stroke prevention management and patients' knowledge of AF and warfarin therapy in Hong Kong (HK).Hypothesis:Both physician and patient's knowledge on warfarin use were the barriers for stroke prevention in patients with atrial fibrillation in Hong Kong.Methods:This prospective survey‐based study was conducted between February 2011 and April 2011 to assess physicians' perceptions of stroke prevention management, patients' knowledge of AF, and patients' knowledge of warfarin therapy. The results were scored and compared with those in foreign countries.Results:Sixty‐two physicians and 114 warfarin users were recruited in the study. The average score of HK physicians in the knowledge of stroke prevention therapy in AF patients was lower than that of Australian (AUS) family physicians (HK 2.48 vs AUS 4.02 out of 7). The mean scores of AF patients in Hong Kong regarding the knowledge of AF were lower than that of United Kingdom (UK) (HK 1.16 vs UK 2.24 out of 4) (P < 0.001) and that of Finland (FIN) (HK 2.77 vs FIN 5.94 out of 8) (P < 0.001), respectively. The mean score of AF patients in Hong Kong regarding the knowledge of warfarin therapy was lower than that of AF patients in the United States (US) (HK 2.39 vs US 3.92).Conclusions:The barriers of warfarin use for AF patients in Hong Kong were related to both physicians and patients. Many Hong Kong physicians did not comply with international recommendations of stroke prevention in AF patients, and AF patients had a low knowledge level about the disease and warfarin therapy.Presented at the International Congress of Cardiology, Hong Kong, Peoples Republic of China, February 24‐26, 2012.This study was supported by the School of Pharmacy, the Chinese University of Hong Kong.The authors have no other funding, financial relationships, or conflicts of interest to disclose.

show abstract

Section: Questionnaire For Patientsmentioning

confidence: 82%

Section: Discussionmentioning

confidence: 99%

Section: Questionnaire For Patientsmentioning

confidence: 90%

Section: Questionnaire For Patientsmentioning

confidence: 94%

Section: Methodsmentioning

confidence: 99%

See 3 more Smart Citations

Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong

Lee

Tam

Yan

et al. 2012

Clinical Cardiology

View full text Add to dashboard Cite

show abstract

Rebuttal: Response to a letter about the cardioseal device

Tobis

2009

Cathet Cardio Intervent

View full text Add to dashboard Cite

Rebuttal: Response to a Letter About the CardioSeal Device TO THE EDITOR I welcome this controversy from my esteemed colleagues. As members of the Editorial Board for Catheterization and Cardiovascular Interventions, we are asked to provide editorials that demonstrate our opinion about a topic raised by the articles published. The purpose is to flush out the details and nuances beyond the data that can be described in a paper.My observation is that interventional cardiologists are not preselected for timid qualities. The authors of these letters have strong opinions about the devices described for ASD or PFO closure. As an experienced operator, I have my own opinions which I expressed in the editorial, suggesting that, ''The CardioSeal/Starflex device should be graciously retired.'' I'm glad to see that my comments stimulated this discussion. It raises questions that all operators can think about when they are trying to decide what equipment is best for their patients.Perhaps I was too subtle in my editorial so that my friends who wrote these letters did not completely understand my points. Let me summarize them here:1. The CardioSeal/Starflex device is not an adequate self centering device and is not an optimal ASD closure device. In most operators' experience, the Amplatzer device is much more effective for closing ASDs. 2. As for closure of PFOs, all of the devices are being used off label without FDA approval. We should make every effort to enroll appropriate patients in the randomized trials for stroke or migraine. 3. There is a 20% incidence of thrombus on the CardioSeal device at 2-4 weeks post implantation. 4. There is a 3% stroke or embolic event rate when the CardioSeal is used for PFO closures. Perhaps some of these emboli are due to atherosclerotic disease, perhaps not. It is impossible to know, but the fact that there is a high frequency of documented thrombus on the device makes me more suspicious that the device is the source of emboli rather than the ascending aorta. 5. The CardioSeal/Starflex is a poor PFO closure device. If the tunnel is long, the arms of the umbrella often force the PFO to open more than it was before. This might explain some of the alleged 35% residual shunt rate in the MIST Trial. 6. The company that makes this device and sponsored the MIST trial, NMT, is suing the original cardiology principal investigator, Peter Wilmshurst, in an effort to silence his criticisms. In my 35 years in academic medicine, I've never heard of such an egregious attempt to suppress scientific dialogue. Perhaps with a new CEO now at NMT, they will drop this self-detrimental lawsuit. Until the 6 month echo data for frequency and severity of residual shunts is clarified from the MIST trail, we will be left with uncertainty about this device. This has lead to the assumption from the neurology community that PFO closure does not reduce migraine frequency and inhibits their interest in entering patients into ongoing clinical trials. Until the effectiveness for complete closure with the CardioSeal is known...

show abstract

Can nurses help improve self‐care of patients living with atrial fibrillation? A focus group study exploring patients' disease knowledge gaps

et al. 2020

View full text Add to dashboard Cite

Aims To identify knowledge gaps and preferences for educational material to improve nurse–patient communication and self‐care. Design Using a mixed‐methods design, we conducted focus groups and quantitative surveys. Methods We conducted three focus groups with atrial fibrillation (AF) patients and support persons (N = 17 participants; 66 ± 16 years) at critical treatment junctures (recent diagnosis or medication switch). Patients and support persons were also surveyed on patient activation (self‐management skills and knowledge), medication adherence, AF knowledge and health literacy. Iterative thematic analysis was performed using focus group transcripts. Results Although most participants had adequate health literacy, most reported gaps in AF knowledge. Participants lacked disease‐related knowledge and were unsure how to manage health behaviours (e.g. diet and exercise). Few felt they received adequate education from their healthcare provider. Results emphasize the need for consistent information from nursing staff, in lay language, via both electronic and printed means.

show abstract

Patient knowledge of atrial fibrillation: 3‐month follow‐up after an emergency room visit

Abstract: Informational support should be available for patients with atrial fibrillation during and after the emergency room visit. The knowledge test introduced in this paper could be developed to evaluate the educational needs of individual patients.

Cited by 37 publications

References 40 publications

Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong

Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong

Rebuttal: Response to a letter about the cardioseal device

Can nurses help improve self‐care of patients living with atrial fibrillation? A focus group study exploring patients' disease knowledge gaps

Contact Info

Product

Resources

About